ELOXX PHARMACEUTICALS, INC. Operating Cash Flow
ELOXX PHARMACEUTICALS, INC. (ELOX) reported Operating Cash Flow of -$10.24 million for the 6-month period ending 2026-06-30, per its S-1 filed 2026-09-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-09-11
- ELOXX PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$4.79M.
- ELOXX PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$5.45M, a 552.91% decline year-over-year.
- ELOXX PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-06-30 was -$1.75M.
- ELOXX PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-03-31 was $1.20M.
- ELOXX PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$31.84M.
- ELOXX PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for fiscal 2021 was -$35.00M.
- ELOXX PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for fiscal 2020 was -$28.17M.
- ELOXX PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for fiscal 2019 was -$39.39M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 159 month | Net Cash Provided by (Used in) Operating Activities 162 month | Net Cash Provided by (Used in) Operating Activities 165 month | Net Cash Provided by (Used in) Operating Activities 168 month | Net Cash Provided by (Used in) Operating Activities 171 month | Net Cash Provided by (Used in) Operating Activities 174 month | Net Cash Provided by (Used in) Operating Activities 177 month | Net Cash Provided by (Used in) Operating Activities 180 month | Net Cash Provided by (Used in) Operating Activities 183 month | Net Cash Provided by (Used in) Operating Activities 186 month | Net Cash Provided by (Used in) Operating Activities 189 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$4.79M derived: S-1 6 month − S-1/A 3 month · filed 2026-09-11 | -$10.24M S-1 · filed 2026-09-11 | |||||||||||||
| 2026-03-31 | -$5.45M S-1/A · filed 2026-06-04 | ||||||||||||||
| 2025-12-31 | -$6.33M S-1 · filed 2026-09-11 | ||||||||||||||
| 2025-06-30 | -$1.75M derived: S-1 6 month − S-1/A 3 month · filed 2026-09-11 | -$549.00K S-1 · filed 2026-09-11 | |||||||||||||
| 2025-03-31 | $1.20M S-1/A · filed 2026-06-04 | ||||||||||||||
| 2024-12-31 | -$4.71M S-1 · filed 2026-09-11 | ||||||||||||||
| 2023-12-31 | -$2.01M derived: S-1 12 month − 10-Q 9 month · filed 2026-09-11 | -$5.46M derived: sum of 2 quarters · filed 2026-09-11 | -$7.53M derived: sum of 3 quarters · filed 2026-09-11 | -$14.34M S-1 · filed 2026-09-11 | |||||||||||
| 2023-09-30 | -$3.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$5.52M derived: sum of 2 quarters · filed 2023-11-13 | -$12.33M 10-Q · filed 2023-11-13 | -$17.99M derived: sum of 4 quarters · filed 2023-11-13 | |||||||||||
| 2023-06-30 | -$2.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | -$8.88M 10-Q · filed 2023-08-11 | -$14.54M derived: sum of 3 quarters · filed 2023-08-11 | -$21.49M derived: sum of 4 quarters · filed 2023-11-13 | |||||||||||
| 2023-03-31 | -$6.81M 10-Q · filed 2023-05-12 | -$12.47M derived: sum of 2 quarters · filed 2023-05-12 | -$19.42M derived: sum of 3 quarters · filed 2023-11-13 | -$29.17M derived: sum of 4 quarters · filed 2023-11-13 | |||||||||||
| 2022-12-31 | -$5.66M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$12.61M derived: sum of 2 quarters · filed 2023-11-13 | -$22.35M derived: sum of 3 quarters · filed 2023-11-13 | -$31.84M 10-K · filed 2023-03-31 | |||||||||||
| 2022-09-30 | -$6.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$16.69M derived: sum of 2 quarters · filed 2023-11-13 | -$26.18M 10-Q · filed 2023-11-13 | -$36.12M derived: sum of 4 quarters · filed 2023-11-13 | |||||||||||
| 2022-06-30 | -$9.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | -$19.24M 10-Q · filed 2023-08-11 | -$29.17M derived: sum of 3 quarters · filed 2023-08-11 | -$36.76M derived: sum of 4 quarters · filed 2023-08-11 | |||||||||||
| 2022-03-31 | -$9.49M 10-Q · filed 2023-05-12 | -$19.42M derived: sum of 2 quarters · filed 2023-05-12 | -$27.01M derived: sum of 3 quarters · filed 2023-05-12 | -$36.81M derived: sum of 4 quarters · filed 2023-05-12 | |||||||||||
| 2021-12-31 | -$9.93M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$17.52M derived: sum of 2 quarters · filed 2023-03-31 | -$27.32M derived: sum of 3 quarters · filed 2023-03-31 | -$35.00M 10-K · filed 2023-03-31 | |||||||||||
| 2021-09-30 | -$7.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$17.39M derived: sum of 2 quarters · filed 2022-11-10 | -$25.07M 10-Q · filed 2022-11-10 | -$29.74M derived: sum of 4 quarters · filed 2022-11-10 | |||||||||||
| 2021-06-30 | -$9.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$17.48M 10-Q · filed 2022-08-12 | -$22.15M derived: sum of 3 quarters · filed 2022-08-12 | -$27.41M derived: sum of 4 quarters · filed 2022-08-12 | |||||||||||
| 2021-03-31 | -$7.68M 10-Q · filed 2022-05-06 | -$12.35M derived: sum of 2 quarters · filed 2022-05-06 | -$17.61M derived: sum of 3 quarters · filed 2022-05-06 | -$23.93M derived: sum of 4 quarters · filed 2022-05-06 | |||||||||||
| 2020-12-31 | -$4.67M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | -$9.93M derived: sum of 2 quarters · filed 2022-03-30 | -$16.24M derived: sum of 3 quarters · filed 2022-03-30 | -$28.17M 10-K · filed 2022-03-30 | |||||||||||
| 2020-09-30 | -$5.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | -$11.57M derived: sum of 2 quarters · filed 2021-11-08 | -$23.50M 10-Q · filed 2021-11-08 | -$32.76M derived: sum of 4 quarters · filed 2022-03-30 | |||||||||||
| 2020-06-30 | -$6.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | -$18.24M 10-Q · filed 2021-08-16 | -$27.50M derived: sum of 3 quarters · filed 2022-03-30 | -$38.82M derived: sum of 4 quarters · filed 2022-03-30 | |||||||||||
| 2020-03-31 | -$11.92M 10-Q · filed 2021-05-07 | -$21.18M derived: sum of 2 quarters · filed 2022-03-30 | -$32.50M derived: sum of 3 quarters · filed 2022-03-30 | -$42.13M derived: sum of 4 quarters · filed 2022-03-30 | |||||||||||
| 2019-12-31 | -$9.26M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | -$20.58M derived: sum of 2 quarters · filed 2022-03-30 | -$30.20M derived: sum of 3 quarters · filed 2022-03-30 | -$39.39M 10-K · filed 2022-03-30 | |||||||||||
| 2019-09-30 | -$11.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$20.95M derived: sum of 2 quarters · filed 2020-11-06 | -$30.13M 10-Q · filed 2020-11-06 | -$39.19M derived: sum of 4 quarters · filed 2021-03-12 | |||||||||||
| 2019-06-30 | -$9.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | -$18.81M 10-Q · filed 2020-08-07 | -$27.87M derived: sum of 3 quarters · filed 2021-03-12 | -$35.97M derived: sum of 4 quarters · filed 2021-03-12 | |||||||||||
| 2019-03-31 | -$9.19M 10-Q · filed 2020-05-08 | -$18.25M derived: sum of 2 quarters · filed 2021-03-12 | -$26.35M derived: sum of 3 quarters · filed 2021-03-12 | -$34.86M derived: sum of 4 quarters · filed 2021-03-12 | |||||||||||
| 2018-12-31 | -$9.06M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | -$17.16M derived: sum of 2 quarters · filed 2021-03-12 | -$25.67M derived: sum of 3 quarters · filed 2021-03-12 | -$31.37M 10-K · filed 2021-03-12 | |||||||||||
| 2018-09-30 | -$8.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | -$16.61M derived: sum of 2 quarters · filed 2019-11-06 | -$22.31M 10-Q · filed 2019-11-06 | -$16.01M derived: sum of 4 quarters · filed 2019-11-06 | |||||||||||
| 2018-06-30 | -$8.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$14.21M 10-Q · filed 2019-08-07 | -$7.91M derived: sum of 3 quarters · filed 2019-08-07 | -$8.48M derived: sum of 4 quarters · filed 2019-08-07 | |||||||||||
| 2018-03-31 | -$5.70M 10-Q · filed 2019-05-09 | $603.00K derived: sum of 2 quarters · filed 2019-05-09 | $27.68K derived: sum of 3 quarters · filed 2019-05-09 | -$3.14M derived: sum of 4 quarters · filed 2019-05-09 | |||||||||||
| 2017-12-31 | $6.30M 10-K · filed 2018-03-16 | $5.72M derived: sum of 2 quarters · filed 2018-03-16 | $2.55M derived: sum of 3 quarters · filed 2018-08-10 | -$15.94M 10-K · filed 2020-03-06 | |||||||||||
| 2017-09-30 | -$575.32K 10-Q · filed 2017-11-14 | -$3.75M derived: sum of 2 quarters · filed 2018-08-10 | -$9.67M 10-Q · filed 2018-11-08 | ||||||||||||
| 2017-06-30 | -$3.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | -$5.90M 10-Q · filed 2018-08-10 | |||||||||||||
| 2017-03-31 | -$2.73M 10-Q · filed 2018-05-10 | ||||||||||||||
| 2016-12-31 | -$8.84M 10-K · filed 2019-03-14 | ||||||||||||||
| 2016-09-30 | -$573.74K 10-Q · filed 2017-11-14 | ||||||||||||||
| 2015-12-31 | -$5.74M 10-K · filed 2018-03-16 | ||||||||||||||
| 2014-09-30 | -$1.94M 10-Q · filed 2014-11-14 | -$3.16M derived: sum of 2 quarters · filed 2014-11-14 | -$4.72M derived: sum of 3 quarters · filed 2014-11-14 | -$6.14M derived: sum of 4 quarters · filed 2014-11-14 | |||||||||||
| 2014-06-30 | -$1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-29 | -$2.78M derived: sum of 2 quarters · filed 2014-09-29 | -$4.20M derived: sum of 3 quarters · filed 2014-09-29 | -$4.87M 10-K · filed 2014-09-29 | |||||||||||
| 2014-03-31 | -$1.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-09 | -$2.98M derived: sum of 2 quarters · filed 2014-05-09 | -$3.65M 10-Q · filed 2014-05-09 | -$4.60M derived: sum of 4 quarters · filed 2014-11-14 | -$44.57M 10-Q · filed 2014-05-09 | ||||||||||
| 2013-12-31 | -$1.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-14 | -$2.09M 10-Q · filed 2014-02-14 | -$3.04M derived: sum of 3 quarters · filed 2014-11-14 | -$4.79M derived: sum of 4 quarters · filed 2014-11-14 | -$43.02M 10-Q · filed 2014-02-14 | ||||||||||
| 2013-09-30 | -$670.47K 10-Q · filed 2014-11-14 | -$1.62M derived: sum of 2 quarters · filed 2014-11-14 | -$3.37M derived: sum of 3 quarters · filed 2014-11-14 | -$3.94M derived: sum of 4 quarters · filed 2014-11-14 | -$41.60M 10-Q · filed 2013-11-14 | ||||||||||
| 2013-06-30 | -$946.33K derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-29 | -$2.70M derived: sum of 2 quarters · filed 2014-09-29 | -$3.27M derived: sum of 3 quarters · filed 2014-09-29 | -$3.90M 10-K · filed 2014-09-29 | -$40.93M 10-K · filed 2013-09-11 | ||||||||||
| 2013-03-31 | -$1.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-09 | -$2.32M derived: sum of 2 quarters · filed 2014-05-09 | -$2.96M 10-Q · filed 2014-05-09 | -$4.06M derived: sum of 4 quarters · filed 2014-09-29 | -$39.98M 10-Q · filed 2013-05-15 | ||||||||||
| 2012-12-31 | -$565.41K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-14 | -$1.20M 10-Q · filed 2014-02-14 | -$2.31M derived: sum of 3 quarters · filed 2014-09-29 | -$3.29M derived: sum of 4 quarters · filed 2014-09-29 | -$38.22M 10-Q · filed 2013-02-14 | ||||||||||
| 2012-09-30 | -$636.45K 10-Q · filed 2013-11-14 | -$1.74M derived: sum of 2 quarters · filed 2014-09-29 | -$2.72M derived: sum of 3 quarters · filed 2014-09-29 | -$3.93M derived: sum of 4 quarters · filed 2014-09-29 | -$37.66M 10-Q · filed 2012-11-14 | ||||||||||
| 2012-06-30 | -$1.11M derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-29 | -$2.09M derived: sum of 2 quarters · filed 2014-09-29 | -$3.30M derived: sum of 3 quarters · filed 2014-09-29 | -$4.39M 10-K · filed 2014-09-29 | -$37.02M 10-K/A · filed 2012-10-26 | ||||||||||
| 2012-03-31 | -$980.02K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-15 | -$2.19M derived: sum of 2 quarters · filed 2013-05-15 | -$3.28M 10-Q · filed 2013-05-15 | -$4.30M derived: sum of 4 quarters · filed 2013-09-11 | -$35.91M 10-Q · filed 2012-05-14 | ||||||||||
| 2011-12-31 | -$1.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-14 | -$2.30M 10-Q · filed 2013-02-14 | -$3.32M derived: sum of 3 quarters · filed 2013-09-11 | -$4.61M derived: sum of 4 quarters · filed 2013-09-11 | -$34.93M 10-Q · filed 2012-02-14 | ||||||||||
| 2011-09-30 | -$1.09M 10-Q · filed 2012-11-14 | -$2.11M derived: sum of 2 quarters · filed 2013-09-11 | -$3.40M derived: sum of 3 quarters · filed 2013-09-11 | -$4.88M derived: sum of 4 quarters · filed 2013-09-11 | -$33.73M 10-Q · filed 2011-11-14 | ||||||||||
| 2011-06-30 | -$1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-11 | -$2.31M derived: sum of 2 quarters · filed 2013-09-11 | -$3.79M derived: sum of 3 quarters · filed 2013-09-11 | -$5.39M 10-K · filed 2013-09-11 | |||||||||||
| 2011-03-31 | -$1.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-14 | -$2.76M derived: sum of 2 quarters · filed 2012-05-14 | -$4.37M 10-Q · filed 2012-05-14 | ||||||||||||
| 2010-12-31 | -$1.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-02-14 | -$3.08M 10-Q · filed 2012-02-14 | |||||||||||||
| 2010-09-30 | -$1.61M 10-Q · filed 2011-11-14 | ||||||||||||||
| 2010-06-30 | -$4.74M 10-K/A · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Tevogen Inc. (TVGN) | United States | $0.049B |